Geode Capital Management’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
Other funds holding TELO
PWM
Geode Capital Management's TELO Position: Q3 2026 in Review
Geode Capital Management increased its Telomir Pharmaceuticals (TELO) stake by 29% in Q3 2026, buying an estimated $117K and bringing the position to 438,260 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #3551.
Geode Capital Management first reported a position in TELO in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.7M in Q4 2024. 23 funds tracked by Wall St. Rank hold TELO as of Q3 2026.
- Geode Capital Management held 438,260 shares of Telomir Pharmaceuticals worth $526K as of Q3 2026.
- Geode Capital Management bought 99,385 Telomir Pharmaceuticals shares in Q3 2026, an estimated $117K.
- Telomir Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3551 holding.
- Geode Capital Management first reported a position in Telomir Pharmaceuticals in Q2 2024 and has held it in 10 quarters since.
- Geode Capital Management's Telomir Pharmaceuticals position peaked at $1.7M in Q4 2024.
- 23 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.